Apitope Technology (Bristol)
Latest round
- Series B
Last raised
- Sep 2015
Total raised
- $28M
Investors
- 4
About Apitope Technology (Bristol)
Founded in 2002, Apitope International focuses on creating immunotherapeutic products designed to address autoimmune disorders. The company has undergone a strategic pivot in its operations and was acquired in December 2021 by Worg, a portfolio company of Kaitai Capital, Junson Capital, and Puhua Capital. The acquisition aimed to broaden Worg's offerings through Apitope's treatments for autoimmune diseases. Apitope's headquarters is located in Bristol, UK, where it operates as a subsidiary. David Wraith is noted as the founder, while Keith Martin serves as the CEO.Apitope specializes in innovative therapeutic solutions focused on peptide-based treatments. Their proprietary immunotherapeutic products are designed to modulate immune responses, particularly for conditions such as Multiple Sclerosis and Type 1 Diabetes.10 for the same year. The company aims to expand its market presence into new regions, particularly targeting additional European and North American markets by 2023. The acquisition by Worg is expected to support these initiatives by integrating Apitope's capabilities into Worg's broader therapeutic offerings. Apitope's strategic focus will remain on advancing its innovative peptide-based treatments and fulfilling critical unmet medical needs in the biotech sector.
Who invested in Apitope Technology (Bristol)
4 investors across 2 rounds
See all investors in Apitope Technology (Bristol)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apitope Technology (Bristol)
Who invested in Apitope Technology (Bristol)?
Apitope Technology (Bristol) has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apitope Technology (Bristol) raised?
Apitope Technology (Bristol) has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Apitope Technology (Bristol) last raise money?
Apitope Technology (Bristol)'s most recent round on record is a Series B, in Sep 2015.
What does Apitope Technology (Bristol) do?
Founded in 2002, Apitope International focuses on creating immunotherapeutic products designed to address autoimmune disorders.
Where is Apitope Technology (Bristol) headquartered?
Apitope Technology (Bristol) is headquartered in UK.
Which VCs invest in companies like Apitope Technology (Bristol)?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Apitope Technology (Bristol)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Apitope Technology (Bristol)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.